Digest Network Come funziona
Network
/
Società
Te
Non verificato

Teva Pharmaceutical Industries Limited

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

6 comunicati stampa

Guarda tutti i comunicati
25/07/2024
Salute
Biotecnologia
Sanità
Medicina - Varie
Farmaceutica
Mercato del lavoro
Industria
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
Fonte
Teva Pharmaceutical Industries Limited
Emittente
Business Wire
1.00
0
18/07/2024
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Industria
Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine
Fonte
Teva Pharmaceutical Industries Limited
Emittente
Business Wire
1.00
0
02/07/2024
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Sanità
Farmaceutica
Salute
Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
Fonte
Teva Pharmaceutical Industries Limited
Emittente
Business Wire
1.00
0
28/06/2024
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
Fonte
Teva Pharmaceutical Industries Limited
Emittente
Business Wire
1.00
0
25/06/2024
Mercato del lavoro
Biotecnologia
Salute
Farmaceutica
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
Fonte
Teva Pharmaceutical Industries Limited
Emittente
Business Wire
1.00
0
03/05/2024
Media
Marketing
Comunicazione
Medicina - Varie
Multimedialità
Teva to Present at the 2024 Bank of America Healthcare Conference
Fonte
Teva Pharmaceutical Industries Limited
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0